These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9855268)

  • 1. Healing of cimetidine-resistant Ménétrier's disease by eradication of Helicobacter pylori infection.
    Shimoyama T; Fukuda S; Tanaka M; Mikami T; Yamagata R; Yoshimura T; Haga Y; Murata Y; Munakata A
    J Clin Gastroenterol; 1998 Dec; 27(4):348-50. PubMed ID: 9855268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ménétrièr's disease associated with Helicobacter pylori infection: resolution of enlarged gastric folds and hypoproteinemia after antibacterial treatment.
    Kawasaki M; Hizawa K; Aoyagi K; Nakamura S; Fujishima M
    Am J Gastroenterol; 1997 Oct; 92(10):1909-12. PubMed ID: 9382064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resolution of Ménétrier's disease after Helicobacter pylori eradicating therapy.
    Di Vita G; Patti R; Aragona F; Leo P; Montalto G
    Dig Dis; 2001; 19(2):179-83. PubMed ID: 11549830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful symptomatic management of a patient with Ménétrier's disease with long-term antibiotic treatment.
    Raderer M; Oberhuber G; Templ E; Wagner L; Pötzi R; Wrba F; Hejna M; Base W
    Digestion; 1999; 60(4):358-62. PubMed ID: 10394031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ecabet sodium eradicates Helicobacter pylori infection in gastric ulcer patients.
    Shimoyama T; Fukuda Y; Fukuda S; Munakata A; Yoshida Y; Shimoyama T
    J Gastroenterol; 1996 Nov; 31 Suppl 9():59-62. PubMed ID: 8959522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healing of protein losing hypertrophic gastropathy by eradication of Helicobacter pylori--is Helicobacter pylori a pathogenic factor in Ménétrier's disease?
    Bayerdörffer E; Ritter MM; Hatz R; Brooks W; Ruckdeschel G; Stolte M
    Gut; 1994 May; 35(5):701-4. PubMed ID: 8200570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the depth of gastric ulceration influence a modified dual therapy with amoxicillin and lansoprazole for Helicobacter pylori-associated gastric ulcer?
    Okai T; Ohtsubo K; Sakai J; Watanabe H; Motoo Y; Kawashima A; Sawabu N
    Can J Gastroenterol; 2000 Oct; 14(9):761-6. PubMed ID: 11064311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of ecabet sodium for Helicobacter pylori eradication triple therapy in comparison with a lansoprazole-based regimen.
    Adachi K; Ishihara S; Hashimoto T; Hirakawa K; Ishimura N; Niigaki M; Kaji T; Kawamura A; Sato H; Fujishiro H; Hattori S; Watanabe M; Kinoshita Y
    Aliment Pharmacol Ther; 2001 Aug; 15(8):1187-91. PubMed ID: 11472321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ménétrier's disease in a patient with Helicobacter pylori infection is linked to elevated glucagon-like peptide-2 activity.
    Watanabe K; Beinborn M; Nagamatsu S; Ishida H; Takahashi S
    Scand J Gastroenterol; 2005 Apr; 40(4):477-81. PubMed ID: 16028444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
    Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
    Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
    [TBL] [Abstract][Full Text] [Related]